See All Slides - tctmd.com

Slides

Presentation TCT 2015

From PRAMI, CvLPRIT, and Other Studies to COMPLETE: What Answers Can We Expect (and Not Expect) From COMPLETE?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Shamir R. Mehta

October 11, 2015

Presentation TCT 2015

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Presenter: Taehoon Ahn, Robert C. Welsh, Quang Ngoc Nguyen

October 11, 2015

Presentation TCT 2015

New Insights From the Stent for Life Initiative

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Petr Kala

October 11, 2015

Presentation TCT 2015

Stents in CTO: If I Get It Open, Will It Stay Open?

Presenter: Etsuo Tsuchikane, Gerald S. Werner, Sunao Nakamura

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Presentation TCT 2015

Functional Risk Scoring: Fame 3 and Beyond

Presenter: Kevin J. Beatt, Craig R. Smith, William F. Fearon

October 11, 2015

Presentation TCT 2015

Keynote Lecture: If I Had Uncontrolled Hypertension

Presenter: Farrell O. Mendelsohn, William B. White, Horst Sievert

October 11, 2015

Presentation TCT 2015

Hybrid Revascularization Strategy for AMI Patients: How to Apply

Presenter: Taehoon Ahn, Robert C. Welsh, Christian Juhl Terkelsen

October 11, 2015

Presentation TCT 2015

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Presenter: Hans Krankenberg, Lindsay S. Machan, Herbert D. Aronow

October 11, 2015

Presentation TCT 2015

Setting Up a Successful CTO Program From the Nurse-Tech Perspective

Presenter: Martina Kelly Speight, Dan Hornberger

October 11, 2015

Advertisement

Slides

From PRAMI, CvLPRIT, and Other Studies to COMPLETE: What Answers Can We Expect (and Not Expect) From COMPLETE?

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

New Insights From the Stent for Life Initiative

Stents in CTO: If I Get It Open, Will It Stay Open?

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Functional Risk Scoring: Fame 3 and Beyond

Keynote Lecture: If I Had Uncontrolled Hypertension

Hybrid Revascularization Strategy for AMI Patients: How to Apply

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Setting Up a Successful CTO Program From the Nurse-Tech Perspective

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content